Leave a little sharper than you arrived.

News, calculators, learning and daily puzzles — pick any one and leave a little further along.

Today’s puzzle

Once-weekly insulin Awiqli gets FDA green light for kids with type 2 diabetes

Kids with type 2 diabetes now have a new option: the FDA has approved Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available for children aged 10 and older. The approval, backed by adult ONWARDS trial data and a pediatric pharmacokinetic study, could ease the burden of daily injections and help improve adherence in young patients.

OncLive · 2 min

EU greenlights teclistamab monotherapy for multiple myeloma as early as first relapse

OncLive · 3 min

Bladder cancer combo therapy delivers survival gains without sacrificing quality of life

Healio · 2 min

FDA greenlights at-home Skyrizi induction for Crohn's disease

Everything on Curie.MD

NeurologyPlay & LearnLearn what’s new in your field, a few minutes at a time.Start learning CardiologyCalculatorsEnter the case once. See every relevant score, side by side.Open a calculator All fieldsDaily GamesThree new clinical puzzles every morning.Play today

Get Curie’s Weekly Dose

What changed in clinical practice, policy, and coverage, and what it means for your patients.

Subscribe free Free. Weekly. Unsubscribe anytime.